Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Pariser

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|April 12, 2025
The role of regulatory flexibility in the review and approval process of rare disease drug developmentShein-Chung Chow, Anne Pariser, Steven Galson
Journal of Biopharmaceutical Statistics|April 12, 2025
Use of alternative and confirmatory data in support of rare disease drug developmentShein-Chung Chow, Anne Pariser, Steven Galson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Rare cancer trial design: lessons from FDA approvalsHimabindu Gaddipati, Ke Liu, Anne Pariser, et al.
Science Translational Medicine|December 24, 2010
Training the translational scientistRebecca D Jackson, Sherine Gabriel, Anne Pariser, et al.
Methods of Information in Medicine|November 4, 2020
Leveraging the UMLS As a Data Standard for Rare Disease Data Normalization and HarmonizationQian Zhu, Dac-Trung Nguyen, Eric Sid, et al.
Pharmaceutical Medicine|July 8, 2024
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical TrialsGareth Baynam, Simeón Baker, Charles Steward, et al.
Orphanet Journal of Rare Diseases|April 13, 2022
The national economic burden of rare disease in the United States in 2019Grace Yang, Inna Cintina, Anne Pariser, et al.
Journal of Biomedical Semantics|November 13, 2020
An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)Qian Zhu, Dac-Trung Nguyen, Ivan Grishagin, et al.
JMIR Medical Informatics|October 2, 2020
Phenotypically Similar Rare Disease Identification from an Integrative Knowledge Graph for Data Harmonization: Preliminary StudyQian Zhu, Dac-Trung Nguyen, Gioconda Alyea, et al.
Nature Biotechnology|August 9, 2008
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentJinhai Wang, Jay Lozier, Gibbes Johnson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|April 12, 2025
The role of regulatory flexibility in the review and approval process of rare disease drug developmentShein-Chung Chow, Anne Pariser, Steven Galson
Journal of Biopharmaceutical Statistics|April 12, 2025
Use of alternative and confirmatory data in support of rare disease drug developmentShein-Chung Chow, Anne Pariser, Steven Galson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Rare cancer trial design: lessons from FDA approvalsHimabindu Gaddipati, Ke Liu, Anne Pariser, et al.
Science Translational Medicine|December 24, 2010
Training the translational scientistRebecca D Jackson, Sherine Gabriel, Anne Pariser, et al.
Methods of Information in Medicine|November 4, 2020
Leveraging the UMLS As a Data Standard for Rare Disease Data Normalization and HarmonizationQian Zhu, Dac-Trung Nguyen, Eric Sid, et al.
Pharmaceutical Medicine|July 8, 2024
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical TrialsGareth Baynam, Simeón Baker, Charles Steward, et al.
Orphanet Journal of Rare Diseases|April 13, 2022
The national economic burden of rare disease in the United States in 2019Grace Yang, Inna Cintina, Anne Pariser, et al.
Journal of Biomedical Semantics|November 13, 2020
An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)Qian Zhu, Dac-Trung Nguyen, Ivan Grishagin, et al.
JMIR Medical Informatics|October 2, 2020
Phenotypically Similar Rare Disease Identification from an Integrative Knowledge Graph for Data Harmonization: Preliminary StudyQian Zhu, Dac-Trung Nguyen, Gioconda Alyea, et al.
Nature Biotechnology|August 9, 2008
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentJinhai Wang, Jay Lozier, Gibbes Johnson, et al.
Pageof 2